PREVIOUS
✖
Pfizer Inc’s RSV Vaccine
June 11 , 2023
612 days
461
0
- The U.S. Food and Drug Administration (FDA) approved Pfizer Inc's respiratory syncytial virus (RSV) vaccine for older adults.
- This is making it the second shot against the common respiratory disease that can be fatal for seniors.
- Earlier, the FDA approved a similar shot by GSK Plc.
Leave a Reply
Your Comment is awaiting moderation.